Author details

Full Name

Trevor J Kilpatrick

Affiliation

ORCID

Career Start Year

1977

Papers

222

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37584176	The Patient-Determined Disease Steps scale is not interchangeable with the Expanded Disease Status Scale in mild to moderate multiple sclerosis.		2024
36936074	High-efficiency pharmacogenetic ablation of oligodendrocyte progenitor cells in the adult mouse CNS.		2023
36448302	Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity.	Brain	2023
37628757	DNA Methylation Signatures of Multiple Sclerosis Occur Independently of Known Genetic Risk and Are Primarily Attributed to B Cells and Monocytes.	Int J Mol Sci	2023
36765422	Parity is associated with long-term differences in DNA methylation at genes related to neural plasticity in multiple sclerosis.		2023
37325639	Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis.		2023
35216774	Subjective versus objective performance in people with multiple sclerosis using the MSReactor computerised cognitive tests.	Multiple Sclerosis and Related Disorders	2022
35906014	Clinical impact of whole-genome sequencing in patients with early-onset dementia.	Journal of Neurology, Neurosurgery and Psychiatry	2022
36158958	Early predictors of visual and axonal outcomes after acute optic neuritis.	Front Neurol	2022
35441271	White matter tract conductivity is resistant to wide variations in paranodal structure and myelin thickness accompanying the loss of Tyro3: an experimental and simulated analysis.	Brain Structure and Function	2022
35734180	Cladribine Treatment for MS Preserves the Differentiative Capacity of Subsequently Generated Monocytes, Whereas Its Administration Acutely Influences Monocyte Differentiation but Not Microglial Activation.	Frontiers in Immunology	2022
35603749	Gait stability reflects motor tracts damage at early stages of multiple sclerosis.	Multiple Sclerosis Journal	2022
35661564	Impact of telehealth on health care in a multiple sclerosis outpatient clinic during the COVID-19 pandemic.	Multiple Sclerosis and Related Disorders	2022
36542729	Peripapillary Choroidal Neovascular Membrane Masquerading as Unilateral Optic Disc Swelling.		2022
35222231	Autoimmune Encephalitis in Long-Standing Schizophrenia: A Case Report.	Frontiers in Neurology	2021
33847902	Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study.	CNS Drugs	2021
33578423	Neuregulin therapy for multiple sclerosis: an each-way bet?	Brain	2021
34222866	Axonal loss in major sensorimotor tracts is associated with impaired motor performance in minimally disabled multiple sclerosis patients.	Brain Communications	2021
33666314	Functional correlates of motor control impairments in multiple sclerosis: A 7 Tesla task functional MRI study.	Human Brain Mapping	2021
34631417	Identification and Characterisation of cis-Regulatory Elements Upstream of the Human Receptor Tyrosine Kinase Gene .		2021
34566866	MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis.	Front Neurol	2021
34563964	Development of [F]MIPS15692, a radiotracer with inÂ vitro proof-of-concept for the imaging of MER tyrosine kinase (MERTK) in neuroinflammatory disease.	European Journal of Medicinal Chemistry	2021
34556562	Association Between Cognitive Trajectories and Disability Progression in Patients With Relapsing-Remitting Multiple Sclerosis.	Neurology	2021
34844642	The oligodendrocyte-enriched orphan G protein-coupled receptor Gpr62 is dispensable for central nervous system myelination.	Neural Development	2021
32612571	Relapse Patterns in NMOSD: Evidence for Earlier Occurrence of Optic Neuritis and Possible Seasonal Variation.	Front Neurol	2020
32197627	Correction to: Comparison of the effectiveness of a tailored cognitive behavioural therapy with a supportive listening intervention for depression in those newly diagnosed with multiple sclerosis (the ACTION-MS trial): protocol of an assessor-blinded, act	Trials	2020
32006158	The clinical profile of NMOSD in Australia and New Zealand.	J Neurol	2020
32110431	Increased ankle muscle coactivation in the early stages of multiple sclerosis.	Multiple Sclerosis Journal - Experimental, Translational and Clinical	2020
32474286	The MSReactor computerized cognitive battery correlates with the processing speed test in relapsing-remitting multiple sclerosis.	Multiple Sclerosis and Related Disorders	2020
32982904	Multiple Sclerosis as a Syndrome-Implications for Future Management.	Frontiers in Neurology	2020
32922258	Tyro3 Contributes to Retinal Ganglion Cell Function, Survival and Dendritic Density in the Mouse Retina.	Frontiers in Neuroscience	2020
32582008	An Experimental Investigation of White Matter Venous Hemodynamics: Basic Physiology and Disruption in Neuroinflammatory Disease.	Frontiers in Neurology	2020
32959759	Case Report: Confirmation by Metagenomic Sequencing of Visceral Leishmaniasis in an Immunosuppressed Returned Traveler.	Am J Trop Med Hyg	2020
32957057	Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia.	Multiple Sclerosis and Related Disorders	2020
31384479	Early imaging predictors of longer term multiple sclerosis risk and severity in acute optic neuritis.	Mult Scler J Exp Transl Clin	2019
30662865	Assessment of acute kidney injury in neurologically and traumatically injured intensive care patients receiving large vancomycin doses.	International Journal of Critical Illness and Injury Science	2018
30208252	The TAM receptor TYRO3 is a critical regulator of myelin thickness in the central nervous system.	GLIA	2018
29908077	Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis.	Ann Neurol	2018
30134801	Dysequilibrium of the PTH-FGF23-vitamin D axis in relapsing remitting multiple sclerosis; a longitudinal study.	Molecular Medicine	2018
29680795	MonoMac syndrome with associated neurological deficits and longitudinally extensive cord lesion.	BMJ Case Reports	2018
29358753	Pharmacogenetic stimulation of neuronal activity increases myelination in an axon-specific manner.	Nature Communications	2018
28077880	Interleukin-2 receptor-Î± proximal promoter hypomethylation is associated with multiple sclerosis.	Genes and Immunity	2017
28680965	A Brain-Derived Neurotrophic Factor-Based p75 Peptide Mimetic Ameliorates Experimental Autoimmune Neuritis Induced Axonal Pathology and Demyelination.	eNeuro	2017
28674983	Multiple Sclerosis: Basic and Clinical.	Advances in neurobiology	2017
29449825	Technologies for Advanced Gait and Balance Assessments in People with Multiple Sclerosis.	Frontiers in Neurology	2017
29527473	Fibre-specific white matter changes in multiple sclerosis patients with optic neuritis.	Neuroimage Clin	2017
29146953	Achievements and obstacles of remyelinating therapies in multiple sclerosis.	Nat Rev Neurol	2017
28222549	Gait and balance deterioration over a 12-month period in multiple sclerosis patients with EDSS scores â¿¤ 3.0.	NeuroRehabilitation	2017
27600112	Stressful life events and the risk of initial central nervous system demyelination.	Multiple Sclerosis Journal	2017
28082327	A Functional and Neuropathological Testing Paradigm Reveals New Disability-Based Parameters and Histological Features for P0180-190-Induced Experimental Autoimmune Neuritis in C57BL/6 Mice.	Journal of Neuropathology and Experimental Neurology	2017